Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review.
Adult
COVID-19
/ complications
COVID-19 Nucleic Acid Testing
COVID-19 Serological Testing
Echocardiography
Hepatomegaly
/ diagnostic imaging
Histiocytic Necrotizing Lymphadenitis
/ etiology
Humans
Male
Myocarditis
/ diagnostic imaging
SARS-CoV-2
Splenomegaly
/ diagnostic imaging
Stroke Volume
Ventricular Dysfunction, Left
/ diagnostic imaging
COVID-19
Kikuchi-Fujimoto disease
Lymphadenopathy
Myocarditis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
24
10
2021
accepted:
30
12
2021
pubmed:
14
1
2022
medline:
4
2
2022
entrez:
13
1
2022
Statut:
ppublish
Résumé
The association between COVID-19 infection and the development of autoimmune diseases is currently unknown, but there are already reports presenting induction of different autoantibodies by SARS-CoV-2 infection. Kikuchi-Fuimoto disease (KFD) as a form of histiocytic necrotizing lymphadenitis of unknown origin. Here we present a rare case of KFD with heart involvement after COVID-19 infection. To our best knowledge only a few cases of COVID-19-associated KFD were published so far. Based on presented case, we summarize the clinical course of KFD and its association with autoimmune diseases, as well we discuss the potential causes of perimyocarditis in this case. We reviewed the literature regarding cases of "Kikuchi-Fujimoto disease (KFD)" and "COVID-19" and then "KFD" and "heart" or "myocarditis" by searching medical journal databases written in English in PubMed and Google Scholar. Only two cases of KFD after COVID infection have been described so far. SARS-CoV-2 infection can also be a new, potential causative agent of developing KFD.
Sections du résumé
BACKGROUND
The association between COVID-19 infection and the development of autoimmune diseases is currently unknown, but there are already reports presenting induction of different autoantibodies by SARS-CoV-2 infection. Kikuchi-Fuimoto disease (KFD) as a form of histiocytic necrotizing lymphadenitis of unknown origin.
OBJECTIVE
Here we present a rare case of KFD with heart involvement after COVID-19 infection. To our best knowledge only a few cases of COVID-19-associated KFD were published so far. Based on presented case, we summarize the clinical course of KFD and its association with autoimmune diseases, as well we discuss the potential causes of perimyocarditis in this case.
METHODS
We reviewed the literature regarding cases of "Kikuchi-Fujimoto disease (KFD)" and "COVID-19" and then "KFD" and "heart" or "myocarditis" by searching medical journal databases written in English in PubMed and Google Scholar.
RESULTS
Only two cases of KFD after COVID infection have been described so far.
CONCLUSION
SARS-CoV-2 infection can also be a new, potential causative agent of developing KFD.
Identifiants
pubmed: 35024942
doi: 10.1007/s00296-021-05088-8
pii: 10.1007/s00296-021-05088-8
pmc: PMC8757403
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-348Informations de copyright
© 2022. The Author(s).
Références
Dotan A, Muller S, Kanduc D et al (2021) The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 20:102792
doi: 10.1016/j.autrev.2021.102792
Cañas CA (2020) The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses 145:110345. https://doi.org/10.1016/j.mehy.2020.110345
doi: 10.1016/j.mehy.2020.110345
pubmed: 33080459
pmcid: 7556280
Dumas G, Prendki V, Haroche J et al (2014) Kikuchi-fujimoto disease: retrospective study of 91 cases and review of the literature. Med (United States) 93:372–382. https://doi.org/10.1097/MD.0000000000000220
doi: 10.1097/MD.0000000000000220
Papla B, Urbańczyk K, Gałazka K (2008) Histiocytic necrotizing lymphadenitis without granulocytic infiltration (the so called Kikuchi-Fujimoto disease). Pol J Pathol 59:55–61
pubmed: 18655372
Mrówka-Kata K, Kata D, Kyrcz-Krzemień S, Helbig G (2010) Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy. Eur Arch Oto-Rhino-Laryngol 267:5–11. https://doi.org/10.1007/s00405-009-1120-7
doi: 10.1007/s00405-009-1120-7
Wiśniewska K, Pawlak-Buś K, Leszczyński P (2020) Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome—literature review based on a case report. Reumatologia 58:251–256. https://doi.org/10.5114/REUM.2020.98438
doi: 10.5114/REUM.2020.98438
pubmed: 32921833
pmcid: 7477469
Szczurowska A, Pawlowski T, Halon A, Skoczynska A (2017) A white man with Kikuchi-Fujimoto disease mimicking lymphoma, preceded by frequent episodes of tonsillitis: a case report. J Med Case Rep 11:1–5. https://doi.org/10.1186/s13256-017-1208-4
doi: 10.1186/s13256-017-1208-4
Seong GM, Kim JH, Lim GC, Kim J (2012) Clinicopathological review of immunohistochemically defined Kikuchi-Fujimoto disease—including some interesting cases. Clin Rheumatol 31:1463–1469. https://doi.org/10.1007/s10067-012-2036-y
doi: 10.1007/s10067-012-2036-y
pubmed: 22875699
Joean O, Thiele T, Raap M et al (2018) Take a second look: it’s Kikuchi’s disease! A case report and review of literature. Clin Pract 8:6–8. https://doi.org/10.4081/cp.2018.1095
doi: 10.4081/cp.2018.1095
Cheng CY, Sheng WH, Lo YC et al (2010) Clinical presentations, laboratory results and outcomes of patients with Kikuchi’s disease: emphasis on the association between recurrent Kikuchi’s disease and autoimmune diseases. J Microbiol Immunol Infect 43:366–371. https://doi.org/10.1016/S1684-1182(10)60058-8
doi: 10.1016/S1684-1182(10)60058-8
pubmed: 21075702
Kwon S-Y, Kim T-K, Kim Y-S et al (2004) CT findings in Kikuchi disease: analysis of 96 cases. Am J Neuroradiol 25:1099 LP – 1102
Kucukardali Y, Solmazgul E, Kunter E et al (2007) Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol 26:50–54. https://doi.org/10.1007/s10067-006-0230-5
doi: 10.1007/s10067-006-0230-5
pubmed: 16538388
Rezai K, Kuchipudi S, Chundi V et al (2004) Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis an Off Publ Infect Dis Soc Am 39:e124–e126. https://doi.org/10.1086/426144
doi: 10.1086/426144
Chen P-H, Huang Y-F, Tang C-W et al (2010) Kikuchi-Fujimoto disease: an amazing response to hydroxychloroquine. Eur J Pediatr 169:1557–1559. https://doi.org/10.1007/s00431-010-1256-x
doi: 10.1007/s00431-010-1256-x
pubmed: 20645108
Noursadeghi M, Aqel N, Gibson P, Pasvol G (2006) Successful treatment of severe Kikuchi’s disease with intravenous immunoglobulin. Rheumatology (Oxford) 45:235–237
doi: 10.1093/rheumatology/kei074
Faheem B, Kumar V, Ashkar H et al (2020) Recurrent Kikuchi-Fujimoto disease masquerading as lymphoma successfully treated by Anakinra. Cureus. https://doi.org/10.7759/cureus.11655
doi: 10.7759/cureus.11655
pubmed: 33391894
pmcid: 7769493
Stimson L, Stitson R, Bahhadi-Hardo M, Renaudon-Smith E (2021) COVID-19 associated Kikuchi-Fujimoto disease. Br J Haematol 192:e124–e126. https://doi.org/10.1111/bjh.17292
doi: 10.1111/bjh.17292
pubmed: 33289068
Racette SD, Alexiev BA, Angarone MP et al (2021) Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report. BMC Infect Dis 21:1–4. https://doi.org/10.1186/s12879-021-06048-0
doi: 10.1186/s12879-021-06048-0
Al SH, Ibrahim W, Al MM et al (2021) Kikuchi-Fujimoto disease following SARS CoV2 vaccination: case report. IDCases 25:e01253. https://doi.org/10.1016/j.idcr.2021.e01253
doi: 10.1016/j.idcr.2021.e01253
Jaseb K, Nameh Goshay Fard N, Rezaei N et al (2021) COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Reports 9:1279–1282. https://doi.org/10.1002/ccr3.3748
doi: 10.1002/ccr3.3748
Sangiorgio V, Veloza L, Galvis K et al (2019) Kikuchi-Fujimoto disease and breast implants: is there a relationship? Haematologica 104:e581–e584. https://doi.org/10.3324/haematol.2019.229831
doi: 10.3324/haematol.2019.229831
pubmed: 31582552
pmcid: 6959175
Maruyama T, Nishihara K, Saio M et al (2017) Kikuchi-Fujimoto disease in the regional lymph nodes with node metastasis in a patient with tongue cancer: a case report and literature review. Oncol Lett 14:257–263. https://doi.org/10.3892/ol.2017.6139
doi: 10.3892/ol.2017.6139
pubmed: 28693162
pmcid: 5494837
Wilkinson CE, Nichol F (2000) Kikuchi-Fujimoto disease associated with polymyositis. Rheumatology 39:1302–1304. https://doi.org/10.1093/rheumatology/39.11.1302
doi: 10.1093/rheumatology/39.11.1302
pubmed: 11085822
Aqel NM, Amr SS, Najjar MM, Henry K (1997) Kikuchi’s lymphadenitis developing in a patient with mixed connective tissue disease and Hashimoto’s thyroiditis. Rheumatology 36:1236–1238. https://doi.org/10.1093/oxfordjournals.rheumatology.a031439
doi: 10.1093/oxfordjournals.rheumatology.a031439
Baenas DF, Diehl FA, Haye Salinas MJ et al (2016) Kikuchi-Fujimoto disease and systemic lupus erythematosus. Int Med Case Rep J 9:163–167. https://doi.org/10.2147/IMCRJ.S106396
doi: 10.2147/IMCRJ.S106396
pubmed: 27418858
pmcid: 4935008
Conrad K, Röber N, Andrade LEC, Mahler M (2017) The clinical relevance of anti-DFS70 Autoantibodies. Clin Rev Allergy Immunol 52:202–216. https://doi.org/10.1007/s12016-016-8564-5
doi: 10.1007/s12016-016-8564-5
pubmed: 27350273
Jung HJ, Lee IJ, Yoon SH (2020) Risk assessment of recurrence and autoimmune disorders in kikuchi disease. Risk Manag Healthc Policy 13:1687–1693. https://doi.org/10.2147/RMHP.S271283
doi: 10.2147/RMHP.S271283
pubmed: 33061702
pmcid: 7519817
Mathew LM, Kapila R, Schwartz RA et al (2016) Kikuchi-Fujimoto disease: a diagnostic dilemma. Int J Dermatol 55(10):1069–1075. https://doi.org/10.1111/ijd.13314
doi: 10.1111/ijd.13314
pubmed: 27207311
Jung IY, Ann HW, Kim JJ et al (2017) The incidence and clinical characteristics by gender differences in patients with Kikuchi-Fujimoto disease. Med (United States). https://doi.org/10.1097/MD.0000000000006332
doi: 10.1097/MD.0000000000006332
pmcid: 5545605
Ruaro B, Sulli A, Alessandri E et al (2014) Kikuchi-Fujimoto’s disease associated with systemic lupus erythematous: difficult case report and literature review. Lupus 23:939–944. https://doi.org/10.1177/0961203314530794
doi: 10.1177/0961203314530794
pubmed: 24739458
Dalugama C, Gawarammana IB (2017) Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report. J Med Case Rep 11:1–4. https://doi.org/10.1186/s13256-017-1521-y
doi: 10.1186/s13256-017-1521-y
Toribio KA, Kamino H, Hu S et al (2015) Co-occurrence of Kikuchi-Fujimoto’s disease and Still’s disease: case report and review of previously reported cases. Clin Rheumatol 34:2147–2153. https://doi.org/10.1007/s10067-014-2755-3
doi: 10.1007/s10067-014-2755-3
pubmed: 25098416
Khan FY, Morad NA, Fawzy Z (2007) Kikuchi’s disease associated with hemophagocytosis. Chang Gung Med J 30:370–373
pubmed: 17939267
Kampitak T (2008) Fatal Kikuchi-Fujimoto disease associated with SLE and hemophagocytic syndrome: a case report. Clin Rheumatol 27:1073–1075. https://doi.org/10.1007/s10067-008-0902-4
doi: 10.1007/s10067-008-0902-4
pubmed: 18465190
O’Malley DP, Grimm KE (2013) Reactive lymphadenopathies that mimic lymphoma: entities of unknown etiology. Semin Diagn Pathol 30:137–145. https://doi.org/10.1053/j.semdp.2012.08.007
doi: 10.1053/j.semdp.2012.08.007
pubmed: 23537913
Pileri SA, Facchetti F, Ascani S et al (2001) Myeloperoxidase expression by histiocytes in Kikuchi’s and Kikuchi-like lymphadenopathy. Am J Pathol 159:915–924. https://doi.org/10.1016/S0002-9440(10)61767-1
doi: 10.1016/S0002-9440(10)61767-1
pubmed: 11549584
pmcid: 1850446
Nishiwaki M, Hagiya H, Kamiya T (2016) Kikuchi-Fujimoto disease complicated with reactive hemophagocytic lymphohistiocytosis. Acta Med Okayama 70:383–388. https://doi.org/10.18926/AMO/54597
doi: 10.18926/AMO/54597
pubmed: 27777431
Barbat B, Jhaj R, Khurram D (2017) Fatality in Kikuchi-Fujimoto disease: a rare phenomenon. World J Clin Cases 5:35. https://doi.org/10.12998/wjcc.v5.i2.35
doi: 10.12998/wjcc.v5.i2.35
pubmed: 28255545
pmcid: 5314258
da Silva AF, Focaccia R, de Oliveira AC et al (2010) Kikuchi-Fujimoto disease: an unusual association with acute renal failure. Braz J Infect Dis 14:621–627. https://doi.org/10.1016/s1413-8670(10)70121-5
doi: 10.1016/s1413-8670(10)70121-5
pubmed: 21340304
Chan JK, Wong KC, Ng CS (1989) A fatal case of multicentric Kikuchi’s histiocytic necrotizing lymphadenitis. Cancer 63:1856–1862. https://doi.org/10.1002/1097-0142(19900501)63:9%3c1856::aid-cncr2820630933%3e3.0.co;2-#
doi: 10.1002/1097-0142(19900501)63:9<1856::aid-cncr2820630933>3.0.co;2-#
pubmed: 2784712
Quintás-Cardama A, Fraga M, Cozzi SN et al (2003) Fatal Kikuchi-Fujimoto disease: the lupus connection. Ann Hematol 82:186–188. https://doi.org/10.1007/s00277-003-0611-7
doi: 10.1007/s00277-003-0611-7
pubmed: 12634955
Beşler MS, Arslan H (2020) Acute myocarditis associated with COVID-19 infection. Am J Emerg Med 38:2489.e1-2489.e2. https://doi.org/10.1016/j.ajem.2020.05.100
doi: 10.1016/j.ajem.2020.05.100
Bonow RO, Fonarow GC, O’Gara PT, Yancy CW (2020) Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol 5:751–753. https://doi.org/10.1001/jamacardio.2020.1105
doi: 10.1001/jamacardio.2020.1105
pubmed: 32219362
Kim IC, Kim JY, Kim HA, Han S (2020) COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J 41:1859. https://doi.org/10.1093/eurheartj/ehaa288
doi: 10.1093/eurheartj/ehaa288
pubmed: 32282027
Volis I, Livneh I, Hussein K, Raz-Pasteur A (2021) COVID-19-associated suspected myocarditis as the etiology for recurrent and protracted fever in an otherwise healthy adult. Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.11.001
doi: 10.1016/j.amjms.2020.11.001
pubmed: 33546881
Ho JS, Sia CH, Chan MY et al (2020) Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung 49:681–685. https://doi.org/10.1016/j.hrtlng.2020.08.013
doi: 10.1016/j.hrtlng.2020.08.013
pubmed: 32861884
pmcid: 7440036
Sardari A, Tabarsi P, Borhany H et al (2021) Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imaging 22:131–132. https://doi.org/10.1093/ehjci/jeaa166
doi: 10.1093/ehjci/jeaa166
pubmed: 32462177
Kamal M, Abo Omirah M, Hussein A, Saeed H (2020) Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. https://doi.org/10.1111/ijcp.13746
doi: 10.1111/ijcp.13746
pubmed: 32991035
Xu S, Sun W, Liu J (2019) Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures. BMC Oral Health 19:1–5. https://doi.org/10.1186/s12903-019-0920-4
doi: 10.1186/s12903-019-0920-4